Business description: PCAS

- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 2025-05-02 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 1999-02-28 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 2014-02-28 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
PCAS SA
21, Chemin de la Sauvegarde
69134, Écully
+33 1 69 09 77 85

Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.25% | -0.47% | +72.43% | +119.36% | 1,052B | ||
| -0.66% | +0.43% | +49.01% | +50.11% | 627B | ||
| -0.54% | +1.39% | +21.88% | +63.83% | 441B | ||
| -1.99% | -3.32% | +41.98% | +34.08% | 349B | ||
| -1.05% | -2.81% | +24.22% | +34.67% | 287B | ||
| -2.12% | -3.67% | -1.09% | +3.11% | 241B | ||
| -0.63% | +1.04% | +43.03% | +59.10% | 224B | ||
| -1.19% | -3.41% | -9.18% | -52.41% | 202B | ||
| +0.16% | +3.87% | +16.25% | +73.27% | 172B | ||
| Average | -0.66% | +0.43% | +28.73% | +42.79% | 399.46B | |
| Weighted average by Cap. | -0.09% | +0.32% | +41.31% | +62.03% |

















